46. 悪性関節リウマチ Malignant rheumatoid arthritis Clinical trials / Disease details
臨床試験数 : 4,325 / 薬物数 : 2,671 - (DrugBank : 417) / 標的遺伝子数 : 187 - 標的パスウェイ数 : 224
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02105129 (ClinicalTrials.gov) | May 2014 | 19/3/2014 | A Study of the Safety, Tolerability and Pharmacokinetics of HMPL-523 | A Phase I, Randomized, Double Blind, Placebo-controlled, Dose-escalating Study of the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of HMPL-523 | Rheumatoid Arthritis (RA) | Drug: HMPL-523;Drug: Placebo | Hutchison Medipharma Limited | NULL | Completed | 18 Years | 45 Years | Male | 118 | Phase 1 | Australia |